SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-055704
Filing Date
2021-04-27
Accepted
2021-04-27 17:20:20
Documents
5
Period of Report
2021-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm212669d1_def14a.htm DEF 14A 614853
2 GRAPHIC logo.jpg GRAPHIC 7672
3 GRAPHIC piechart.jpg GRAPHIC 66199
4 GRAPHIC proxy1.jpg GRAPHIC 82168
5 GRAPHIC proxy2.jpg GRAPHIC 62110
  Complete submission text file 0001104659-21-055704.txt   917155
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36860 | Film No.: 21860121
SIC: 2836 Biological Products, (No Diagnostic Substances)